| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |